Repositioned Natural Compounds and Nanoformulations: A Promising Combination to Counteract Cell Damage and Inflammation in Respiratory Viral Infections
A Mariano, I Bigioni, M Marchetti, A Scotto d'Abusco… - Molecules, 2023 - mdpi.com
Respiratory viral diseases are among the most important causes of disability, morbidity, and
death worldwide. Due to the limited efficacy or side effects of many current therapies and the …
death worldwide. Due to the limited efficacy or side effects of many current therapies and the …
Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study
B Wolszczak-Biedrzycka, J Dorf… - Frontiers in …, 2024 - frontiersin.org
Aim The aim of the present study was to assess differences in the serum levels of
chemokines and growth factors (GFs) between COVID-19 patients and healthy controls. The …
chemokines and growth factors (GFs) between COVID-19 patients and healthy controls. The …
Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19
F Azarfar, B Abbasi, A Jalali, MH Abbasian - Cytokine, 2023 - Elsevier
Abstract Background Higher expression of Monocyte Chemoattractant Protein 1 (MCP-1)
was reported in several studies. The clinical severity of Coronavirus disease 2019 (COVID …
was reported in several studies. The clinical severity of Coronavirus disease 2019 (COVID …
[HTML][HTML] Association between clinical characteristics and laboratory findings of 102 patients with COVID-19 in Iraq
GF Hussein, AH Al-Saadi - Medical Journal of Babylon, 2023 - journals.lww.com
Background: The coronavirus epidemic (COVID-19) initially appeared in Wuhan, China in
December, 2019 and then rapidly spread all over the world. The importance of information …
December, 2019 and then rapidly spread all over the world. The importance of information …
[PDF][PDF] Blanka Wolszczak-Biedrzycka1, Justyna Dorf2, Marzena Wojewodzka-Zelezniakowicz3, Małgorzata Zendzian-Piotrowska4, Violetta Dymicka-Piekarska2 …
M Wojewódzka-Zelezniakowicz - 2024 - ppm.umb.edu.pl
Aim: The aim of the present study was to assess differences in the serum levels of
chemokines and growth factors (GFs) between COVID-19 patients and healthy controls. The …
chemokines and growth factors (GFs) between COVID-19 patients and healthy controls. The …
[图书][B] Inflammatory Profiles and Immune Responses to High-Altitude Acclimatization
K Pham - 2023 - search.proquest.com
High altitude is a physiologically stressful environment due to oxygen limitation and low
atmospheric pressure. Despite these conditions, over 160 million people live, work, or travel …
atmospheric pressure. Despite these conditions, over 160 million people live, work, or travel …
Estratificação das concentrações de interleucina 6 com potencial para identificação de novos biomarcadores de prognóstico na COVID-19
SP GOMES - 2023 - repositorio.ufpe.br
A clínica frente a infecção por SARS-CoV-2 é diversificada, podendo variar de leve,
moderada, a grave, contudo, o agravamento ou desfecho fatídico não pode ser explicado …
moderada, a grave, contudo, o agravamento ou desfecho fatídico não pode ser explicado …
Silent Symptoms, Active Immunity: Insights into Early-Stage Cytokine Expressions in Ugandan Mild and Asymptomatic COVID-19 subjects
AK Watelo, V Ankunda, I Ssali, GK Oluka, S Mugaba… - 2023 - researchsquare.com
Background This study examined the early response of individuals with mild and
asymptomatic SARS-CoV-2 infection by analysing cytokine, chemokine, and growth factor …
asymptomatic SARS-CoV-2 infection by analysing cytokine, chemokine, and growth factor …